We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTAI icon
126
BioXcel Therapeutics
BTAI
$26.2M
$3.82M 0.05%
186,688
+163,502
+705% +$5.47M
HYPD
127
Hyperion DeFi Inc
HYPD
$40.3M
$3.6M 0.05%
+75,758
New +$4.39M
PIII icon
128
P3 Health Partners
PIII
$33.3M
$3.56M 0.04%
+158,000
New +$4.72M
MTVA
129
MetaVia Inc
MTVA
$7.64M
$3.37M 0.04%
+63,348
New +$2.71M
PTN
130
Palatin Technologies
PTN
$14.6M
$3.27M 0.04%
+33,562
New +$3.24M
FWRG icon
131
First Watch Restaurant Group
FWRG
$771M
$3.25M 0.04%
+185,000
New +$3.86M
SYRE icon
132
Spyre Therapeutics
SYRE
$8.24B
$3.2M 0.04%
+136,000
New +$4.59M
TFX icon
133
Teleflex
TFX
$6.18B
$3.15M 0.04%
+15,000
New +$3.14M
IPW icon
134
iPower
IPW
$1.01M
$3.04M 0.04%
+6,096
New +$1.93M
TXG icon
135
10x Genomics
TXG
$5.97B
$3M 0.04%
154,482
-3,804
-2% -$99.6K
LEXX icon
136
Lexaria Bioscience
LEXX
$7.85M
$2.84M 0.04%
+68,000
New +$3.06M
ZGN icon
137
Zegna
ZGN
$4.09B
$2.83M 0.04%
239,235
+202,281
+547% +$2.49M
CLSD
138
DELISTED
Clearside Biomedical
CLSD
$2.78M 0.03%
142,400
-121,333
-46% -$2.34M
BCLI
139
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2.68M 0.03%
+527,844
New +$3.96M
BJRI icon
140
BJ's Restaurants
BJRI
$1.44B
$2.6M 0.03%
+75,000
New +$2.57M
ALGS icon
141
Aligos Therapeutics
ALGS
$28.5M
$2.54M 0.03%
290,256
+14,520
+5% +$255K
ENLV icon
142
Enlivex Ltd
ENLV
$36.5M
$2.41M 0.03%
+113,371
New +$3.01M
BLMN icon
143
Bloomin' Brands
BLMN
$774M
$2.4M 0.03%
125,000
+117,977
+1,680% +$2.77M
SRZN icon
144
Surrozen
SRZN
$253M
$2.08M 0.03%
+190,000
New +$1.96M
CMRX
145
DELISTED
Chimerix, Inc.
CMRX
$1.95M 0.02%
2,224,000
-40,000
-2% -$37.9K
AXDX
146
DELISTED
Accelerate Diagnostics
AXDX
$1.88M 0.02%
1,608,000
-238,000
-13% -$249K
SLGL icon
147
Sol-Gel Technologies
SLGL
$268M
$1.81M 0.02%
203,200
-4,600
-2% -$38.3K
IOBT
148
DELISTED
IO Biotech
IOBT
$1.81M 0.02%
1,545,000
-179,000
-10% -$250K
BSX icon
149
Boston Scientific
BSX
$72B
$1.79M 0.02%
+23,300
New +$1.71M
NRSN icon
150
NeuroSense Therapeutics
NRSN
$16.9M
$1.77M 0.02%
+1,584,000
New +$2.02M
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.